SEC Company Response from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW) — Jul 23, 2013
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: July 23, 2013 · CIK: 0001130598 · Accession: 0001104659-13-055805
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-189358
Letter
July 23, 2013
United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549
Attention:
Jeffrey P. Riedler, Assistant Director
Austin Stephenson
Dan Greenspan
Jim Peklenk
Mark Brunhofer
Re: Onconova Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-189358)
Ladies and Gentlemen:
In connection with the above-captioned Registration Statement, we wish to advise that between July 11, 2013 and the date hereof 1,170 copies of the Preliminary Prospectus dated July 11, 2013 were distributed as follows: 220 to prospective underwriters; 790 to institutional investors; 0 to prospective dealers; 160 to individuals; 0 to rating agencies and 0 to others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, July 24, 2013 or as soon thereafter as practicable.
[signature page follows]
Very truly yours,
Citigroup Global Markets Inc.
Show Raw Text
CORRESP 1 filename1.htm July 23, 2013 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Jeffrey P. Riedler, Assistant Director Austin Stephenson Dan Greenspan Jim Peklenk Mark Brunhofer Re: Onconova Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-189358) Ladies and Gentlemen: In connection with the above-captioned Registration Statement, we wish to advise that between July 11, 2013 and the date hereof 1,170 copies of the Preliminary Prospectus dated July 11, 2013 were distributed as follows: 220 to prospective underwriters; 790 to institutional investors; 0 to prospective dealers; 160 to individuals; 0 to rating agencies and 0 to others. We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, July 24, 2013 or as soon thereafter as practicable. [signature page follows] Very truly yours, Citigroup Global Markets Inc. Leerink Swann LLC As representatives of the Prospective Underwriters By: Citigroup Global Markets Inc. By: /s/ Brian Gleason Name: Brian Gleason Title: Director By: Leerink Swann LLC By: /s/ Daniel Dubin Name: Daniel Dubin Title: Vice Chairman Signature Page to Acceleration Request